5q- syndrome
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
|
WikiDoc Resources for 5q- syndrome | |
|
Articles | |
|---|---|
|
Most recent articles on 5q- syndrome Most cited articles on 5q- syndrome | |
|
Media | |
|
Powerpoint slides on 5q- syndrome | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on 5q- syndrome at Clinical Trials.gov Clinical Trials on 5q- syndrome at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on 5q- syndrome
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on 5q- syndrome Discussion groups on 5q- syndrome Patient Handouts on 5q- syndrome Directions to Hospitals Treating 5q- syndrome Risk calculators and risk factors for 5q- syndrome
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for 5q- syndrome | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
5q- syndrome is a rare disorder caused by loss of part of the long arm (q arm, band 5q31.1) of human chromosome 5. This syndrome affects bone marrow cells, causing treatment-resistant anemia, and myelodysplastic syndromes that may lead to acute myelogenous leukemia. Examination of the bone marrow shows characteristic changes in the megakaryocytes. They are more numerous than usual, small and mononuclear. There may be accompanying erythroid hyperplasia.
Lenalidomide is a new agent that is showing promise in treating 5q- syndrome.
References
External links
- 5q- syndrome at NIH's Office of Rare Diseases
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
